Finanzwire Finanzwire
Basculer en Français
11166 Companies
246602 Keywords
174550 Articles
133185 Press releases
Headlines Articles Press releases HanchorBio Inc. Remove
  1. Home
  2. Companies
  3. HanchorBio Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 12/01/2023 at 13:00, 2 years 10 months ago

    HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress

    HanchorBio Inc. announces poster presentation at ESMO-IO 2023 Annual Congress, featuring innovative immuno-biomedicines targeting solid tumors and hematological malignancies
    HanchorBio Inc. ESMO-IO 2023 Immuno-biomedicines Solid Tumors Hematological Malignancies
    Logo of HanchorBio Inc.
  • PRESS RELEASE

    published on 10/03/2023 at 13:30, 3 years ago

    HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101

    Logo of HanchorBio Inc.
  • PRESS RELEASE

    published on 08/28/2023 at 13:30, 3 years 1 month ago

    HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies

    Logo of HanchorBio Inc.
  • PRESS RELEASE

    published on 07/24/2023 at 13:30, 3 years 2 months ago

    HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

    Logo of HanchorBio Inc.
  • PRESS RELEASE

    published on 04/17/2023 at 13:30, 3 years 5 months ago

    HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

    Logo of HanchorBio Inc.
Accesswire
  • Published on 10/13/2026 at 15:00, 18 minutes ago

    Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

  • Published on 10/13/2026 at 14:45, 33 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 47 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 1 hour 8 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 1 hour 18 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 15:06, 11 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 10/13/2026 at 15:05, 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 10/13/2026 at 15:05, 12 minutes ago

    Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats

  • Published on 10/13/2026 at 15:03, 14 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

  • Published on 10/13/2026 at 15:02, 15 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS
Les Echos
  • Published on 10/13/2026 at 09:04, 6 hours 13 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 21 hours 18 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

  • Published on 10/12/2026 at 15:47, 23 hours 30 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy